Profit at Italy's BPER falls less than expected as loan writedowns shrink

MILAN, May 9 (Reuters) - Italy's fifth-largest lender BPER Banca EMII.MI on Monday reported a smaller-than-expected drop in first quarter profit helped by higher revenues and lower loan writedowns.

BPER has minimal exposure to Russia, unlike larger peers UniCredit CRDI.MI and Intesa Sanpaolo ISP.MI which had to book large provisions against loan losses in the first quarter to cover for risks stemming from the Ukraine crisis.

BPER said loan loss provisions totalled 113 million euros, sharply down from 419 million euros a year before.

Net profit for the three months through March was 113 million euros ($119 million), down 72% from 400 million euros a year ago, when it included an around 1 billion euro positive accounting effect stemming from the acquisition of branches.

The figure came significantly above an average forecast of 72 million euros in a Reuters analyst poll.

Revenues rose 9.6% year-on-year driven by higher net interest income and fees as BPER's expanded its domestic footprint by buying branches that Intesa Sanpaolo ISP.MI was forced to offload when it took over rival UBI.

It said revenues were expected to grow in 2022 barring a significant worsening of the geopolitical situation.

BPER in February agreed to buy troubled rival Carige in a deal that propels it further along the expansion path set out by leading shareholder UnipolSAI US.MI , which is looking to build a wide distribution network for its insurance products.

The deal, which will further lift BPER's assets to more than 155 billion euros making it Italy's No.4 lender, is expected to close at the beginning of June, slightly earlier than planned.

BPER will present a new business plan after finalising the acquisition of Carige. ($1 = 0.9488 euros)
Reporting by Andrea Mandalà editing by Valentina Za and Keith Weir

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.